Cyclophosphamide and carboplatin and selective consolidation in advanced seminoma

Clinical Cancer Research

Volumn 6, Issue 1, 2000, Pages 72-77

  Amato, Robert J ^a   Millikan, Randall ^a   Daliani, Dania ^a   Wood, Lori ^a   Logothetis, Christopher ^a   Pollack, Alan ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE;

ADOLESCENT; ADULT; ADVANCED CANCER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; HUMAN; MALE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SEMINOMA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARBOPLATIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; HUMANS; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; PINEAL GLAND; RETROPERITONEAL NEOPLASMS; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 0033980408     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Samuels, M. L., Johnson, D. E., Brown, B., et al. Velban Plus Continuous Infusion Bleomycin (VB-3) in Stage III Advanced Testicular Cancer: Results in 99 Patients with a Note on High-Dose Velban and Sequential Cisplatin in Cancer of the Genitourinary Tract, pp. 159-172. New York: Raven Press, 1979.
2. Higby, D. J., Wallace, D. J., Jr., Albert, D., et al. Diaminodichloroplatin in the chemotherapy of testicular tumors. J. Urol., 112: 100-104, 1974.
3. Calman, F. M. B., Peckham, M. J., and Hendry, W. F. The pattern of spread and treatment of metastases in testicular seminoma. Br. J. Urol., 51: 154-160, 1979.
4. Frei, E., III, Teicher, B. A., Holden, S. A., et al. Preclinical studies and clinical correlation of correlation of the effect of alkylating dose. Cancer Res., 48: 6417-6422, 1977.
5. Chebotareva, L. I. Late results of sarcolysin therapy in tumors of the testis. Acta U. N. Int. Congress on Cancer, pp. 380-384. 1964.
6. Whitmore, W. F., Smith, W. F., and Yagooda, A. Chemotherapy of seminoma. In: E. Grundmann (ed.), Recent Results in Cancer Research, pp. 224-249. Berlin: Springer-Verlag, 1977.
7. Anscher, M. S., Marks, L. B., and Shipley, W. U. The role of radiotherapy in patients with advanced seminomatous germ cell tumors. Oncology, 6: 97-110, 1992.
8. Logothetis, C. J., Samuels, M. L., Ogden, S. L., et al. Cyclophosphamide and sequential cisplatin for advanced seminoma: long term follow up in 52 patients. J. Urol., 138: 789-794, 1987.
9. Amato, R. J., Ellerhorst, M., Banks, M., and Logothetis, C. J. Carboplatin and ifosfamide and selective consolidation in advanced seminoma. Eur. J. Cancer. 31A: 2223-2228, 1995.
10. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
11. Motzer, R., Bosl, G., Heelan, R., et al. Residual mass: an indication for further therapy in patients with advanced seminoma following systemic chemotherapy. J. Clin. Oncol., 5: 1064-1070, 1987.
12. Bajorin, D. F., Sarosdy, M. F., Pfister, D. G. et al. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multi-institutional study. J. Clin. Oncol., 11: 598-606, 1993.
13. Williams, S. D., Birch, R., Einhorn, L. H., et al. Treatment of disseminated germ cell tumors. N. Engl. J. Med., 316: 1435-1440, 1987.
14. Tjulandin, S. A., Khlebnov, A. V., Nasirova, R. J., et al. VAB-6 and cisplatin-cyclophosphamide combinations in the treatment of metastatic seminoma patients: the U.S.S.R. experience. Ann. Oncol., 2: 667-672, 1991.
15. Wilkinson, P. M., Read, G., and Magee, G. The treatment of advanced seminoma with chemotherapy and radiotherapy. Br. J. Cancer, 57: 100-104, 1988.
16. Fossa, S. D., Borge, L., Aass, N., Johannessen, N. B., Stenwig, A. E., and Kaalhus, O. The treatment of advanced metastatic seminoma: experience in 55 cases. J. Clin. Oncol., 5: 1071-1077, 1987.
17. Mencel, P. J., Motzer, R. J., Mazumdar, M., et al. Advanced seminoma: treatment results, survival, and prognostic factors in 142 patients. J. Clin. Oncol., 12: 120-126, 1994.
18. Bosl, G., Geller, N. K., Bajorin, D., et al. A randomized trial of etoposide + cisplatin actinomycin D (VAB-6) in patients with good prognosis germ cell tumors. J. Clin. Oncol., 6: 1231-1238, 1988.
19. Levi, J. A., Raghavan, D., Harvey, V., et al. The importance of bleomycin in combination chemotherapy for good prognosis germ cell carcinoma. J. Clin. Oncol., 11: 1300-1305, 1993.